Cardio Therapeutic Updates

As the volume of clinical trial data, novel therapeutics, and guideline updates continues to accelerate, staying current has become increasingly difficult: even for specialists focused on a single area of innovation.

Cardio Therapeutic Updates addresses this by providing accurate, continuously updated overviews of the most relevant scientific and clinical developments, curated from major journals, guideline bodies, and congress proceedings. Alongside original coverage, the platform links clinicians to relevant educational resources, helping bridge the gap between emerging data and practical, accessible learning.

What is here

• A library of studies, each summarised from its published abstract and linked to its source.
• A trial tracker with registry facts for the outcomes trials in the class.
• The agents, each with mechanism, trial record and development status.
• Guidelines and consensus documents, dated.
• A timeline of what has happened and what is due.
• Educational videos, embedded with their publishers' permission.

This is a reference for professionals; the source, whether a DOI, a registry record or a regulator, remains the truth.

The Cardio Therapeutic Updates collection

The initiative is structured as a growing network of dedicated hubs, each focused on a specific area of therapeutic innovation within cardiovascular medicine. We are launching with two hubs at the forefront of current clinical interest:

• Lp(a) :Tracking the evolving evidence base and emerging therapies targeting lipoprotein(a), a long-overlooked but increasingly actionable cardiovascular risk factor.
• CETP Inhibition: Covering the renewed clinical development in CETP inhibition, following recent trial results that have reignited interest in this therapeutic class.

Additional hubs covering other novel areas of cardiovascular innovation: including established and emerging drug targets: will follow as the initiative expands, with the same commitment to accuracy, timeliness, and expert-informed curation across each.

Cardio Therapeutic Updates exists to make sure that no matter how fast the field moves, clinicians don't have to fall behind to stay informed.

cetpinhibition.org, this site

Evidence-oriented. The CETP-inhibition literature in one library: agents, trials, genetics and studies, each summarised and linked to its source, with new work added as the field produces it.

lp-a.org

Evidence-oriented. Lipoprotein(a) on the same model: studies, trials, guidance and video, kept current. The two libraries overlap where CETP inhibitors affect Lp(a).

hartvaat.nl

Update-oriented. Dutch-language platform for cardiovascular medicine: daily news, video and literature from the international journals, selected and translated for practice in the Netherlands.